ImmunoCAP ISAC (ISAC, Phadia, Uppsala, Sweden) helps to reveal the IgE sensitization profile of multisensitized patients and the potential risk for severe reactions.1 It is also useful for identifying cross-reactive IgE patterns and might direct the treatment of allergic disease.1 This multiplex allergen test enables the measurement of IgE antibodies to a fixed panel of 112 components from 51 allergen sources in a single step, including two major venom components, honeybee rApi m1 and yellow jacket rVes v5 and two additional marker allergens, Api m4 and Pol d5.

中文翻译：

---

IgE 与重组过敏原 Api m 1 和 Ves v 5 的方法学和诊断相关性由多重测试 ImmunoCAP ISAC 确定

ImmunoCAP ISAC（ISAC，Phadia，Uppsala，瑞典）有助于揭示多重过敏患者的 IgE 致敏特征和严重反应的潜在风险。1 它还有助于识别交叉反应性 IgE 模式，并可能指导过敏性疾病的治疗。 1 这种多重过敏原测试能够在一个步骤中测量针对来自 51 种过敏原来源的 112 种固定成分的 IgE 抗体，包括两种主要的毒液成分，蜜蜂 rApi m1 和黄色夹克 rVes v5 以及两种额外的标记过敏原，Api m4 和波尔 d5。